Stay updated on Atrasentan in IgA Nephropathy Clinical Trial

Sign up to get notified when there's something new on the Atrasentan in IgA Nephropathy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atrasentan in IgA Nephropathy Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Adds a recruitment status note indicating the trial is no longer recruiting participants and includes new navigation items such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'; removes the old 'Intervention / Treatment' label in favor of 'Intervention/Treatment' and adds the site revision note 'Revision: v3.6.0'.
    Difference
    0.2%
    Check dated 2026-06-15T17:09:25.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Novartis Pharmaceuticals is now listed as sponsor with new identifiers and drug details added. The study plan now includes an open-label atrasentan extension, a zigakibart substudy, and updated timelines including primary completion in 2028-04-14 and enrollment of 404 participants.
    Difference
    2%
    Check dated 2026-06-08T14:48:40.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A new publication citation was added under Publications. It lists the Kidney360 article on atrasentan in IgA nephropathy (online ahead of print, 2025).
    Difference
    0.0%
    Check dated 2026-06-01T05:27:36.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.5.3 to v3.5.4, indicating a new release of the site framework or content management. This change reflects an internal version update rather than an alteration to the study information or visible user content.
    Difference
    0.0%
    Check dated 2026-05-18T03:27:44.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page’s UI/version label has been updated from “Revision: v3.5.2” to “Revision: v3.5.3” without any accompanying change to the study content.
    Difference
    0.0%
    Check dated 2026-04-26T15:32:49.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T13:47:40.000Z thumbnail image

Stay in the know with updates to Atrasentan in IgA Nephropathy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atrasentan in IgA Nephropathy Clinical Trial page.